Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

Rank in Stocks #4343
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Share Price
$2.43
Market Cap
$3.63B
Change (1 day)
0.48%
Change (1 year)
-9.81%
Country
CN
Trade Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

Category

Healthcare
P/B ratio for Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
P/B ratio as of October 2026 TTM: 2.51
According to Zhejiang Huahai Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.51. At the end of 2023 the company had a P/B ratio of 2.65.
P/B ratio history for Zhejiang Huahai Pharmaceutical Co., Ltd. from 2000 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 2.51 -13.88%
2024 2.92 10.29%
2023 2.65 -36.78%
2022 4.19 -12.79%
2021 4.80 -36.36%
2020 7.54 85.37%
2019 4.07 32.50%
2018 3.07 -52.04%
2017 6.40 24.40%
2016 5.15 -7.28%
2015 5.55 57.53%
2014 3.52 4.58%
2013 3.37 6.18%
2012 3.17 -18.62%
2011 3.90 -27.34%
2010 5.37 -17.31%
2009 6.49 93.63%
2008 3.35 -49.89%
2007 6.69 83.20%
2006 3.65 42.68%
2005 2.56 -17.88%
2004 3.12 42.37%
2003 2.19 -88.84%
2002 19.61 -10.48%
2001 21.91 -10.48%
2000 24.48 0.00%
P/B ratio for similar companies or competitors